Synopsis
This book, published in two volumes, Volume 1 and Volume 2, respectively, represents the most comprehensive and up-to-date collection of current literature on angiotensin inhibition and related topics in medicine, nephrology and cardiovascular medicine ever compiled. Top experts in the various fields of nephrology, hypertension, cardiovascular medicine, pharmacotherapeutics and related fields from all five continents have contributed essays, original papers, reviews and editorial opinions in this volume. This book has turned out to be the most authoritative reference source on ACEIs, with contributions made by leading experts in their various fields of medicine, from the USA, Europe, including the United Kingdom, South America, Australia-New Zealand, Asia including Japan, and Africa. Critically vital clinical topics are covered in this book by top world-renowned experts in different subspecialties, including classic topics such as the efficacy of ACE inhibition as an antihypertensive among the various ethnicities and races, as written from American, African, Caribbean and European perspectives. This volume should indeed serve as a major literature reference text for physicians in general, internists, researchers, cardiologists and hypertension specialists, and especially the practitioners of the art of nephrology in all the countries around the world. Medical students and various physician training programs should reach for a copy of this volume as a research and teaching tool for many years to come. There is also a place here for research scientists in the pharmaceutical industry to review current and newly emerging indications for angiotensin inhibition and the future of reno-protection.
Review
These two books provide a comprehensive review of angiotensin blockade in medicine. Volume 1 describes the pharmacology of angiotensin blockade. The initial chapters describe the history of the discovery of angiotensin converting enzyme inhibitors. The final chapters discuss new developments in angiotensin blockade. In between these are chapters that describe the utility and complications of angiotensin blockers. There are critical reviews of randomized controlled trials in nephrology that make for interesting reading.
Dr. Dwomoa Adu
Honorary Consultant Physician
Accra, Ghana
Volume 2 covers the use of angiotensin blockade in different ethnic groups and geographical locations. There are excellent chapters on the use of angiotensin blockade in African Americans, individuals from ethnic minorities in the UK and in patients from the Caribbean and Africa. Other chapters describe the use on angiotensin blockade in different clinical scenarios including after renal transplantation, HIV associated proteinuria, dialysis patients and renal artery stenosis amongst others.
Dr. Dwomoa Adu
Honorary Consultant Physician
Accra, Ghana
The widespread use of angiotensin blockers means that even if their side effects are infrequent that would nevertheless translate into a lot of patients affected. This is particularly so as most treated patients are elderly and have pre-existing cardiac or renal diseases which of themselves predispose to acute deterioration of renal function. These complications are described in detail. The book carefully details the circumstances in which complications occur in patients on angiotensin blockers and how these might be avoided.
Dr. Dwomoa Adu
Honorary Consultant Physician
Accra, Ghana
Each chapter is written by acknowledged experts in the field who give a clear overview of the subject. The chapters are well referenced. The books are well written and provide information that would be useful to doctors in primary care, internal medicine and it's subspecialties of nephrology and cardiology. This is an excellent referral text and one that is highly recommended.
Dr. Dwomoa Adu
Honorary Consultant Physician
Accra, Ghana
"About this title" may belong to another edition of this title.
